Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Itzykson

Showing results (71-80 of 97) with videos related to

Pageof 10
Sort By:
Blood Advances|August 22, 2018
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesRaphael Itzykson, Simon Crouch, Erica Travaglino, et al.
Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia|April 21, 2023
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Loïc Vasseur, Rathana Kim, et al.
Blood|August 19, 2021
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapyRaphael Itzykson, Elise Fournier, Céline Berthon, et al.
Blood|April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
Blood|September 20, 2013
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disordersFrederik Damm, Virginie Chesnais, Yasunobu Nagata, et al.
Haematologica|June 8, 2019
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromesLouise de Swart, Simon Crouch, Marlijn Hoeks, et al.
American Journal of Hematology|December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patientsSylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.
The Journal of Clinical Investigation|November 15, 2024
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemiaPaul Deschamps, Margaux Wacheux, Axel Gosseye, et al.
Blood|June 6, 2022
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysisMarie Robin, Liesbeth C de Wreede, Eric Padron, et al.
Pageof 10

Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Blood Advances|August 22, 2018
Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromesRaphael Itzykson, Simon Crouch, Erica Travaglino, et al.
Blood|April 29, 2020
CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemiaJohannes Schmoellerl, Inês Amorim Monteiro Barbosa, Thomas Eder, et al.
Leukemia|April 21, 2023
UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemiaNicolas Duployez, Loïc Vasseur, Rathana Kim, et al.
Blood|August 19, 2021
Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapyRaphael Itzykson, Elise Fournier, Céline Berthon, et al.
Blood|April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
Blood|September 20, 2013
BCOR and BCORL1 mutations in myelodysplastic syndromes and related disordersFrederik Damm, Virginie Chesnais, Yasunobu Nagata, et al.
Haematologica|June 8, 2019
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromesLouise de Swart, Simon Crouch, Marlijn Hoeks, et al.
American Journal of Hematology|December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patientsSylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.
The Journal of Clinical Investigation|November 15, 2024
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemiaPaul Deschamps, Margaux Wacheux, Axel Gosseye, et al.
Blood|June 6, 2022
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysisMarie Robin, Liesbeth C de Wreede, Eric Padron, et al.
Pageof 10